PD-L1 Expression and Survival among Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy()

BACKGROUND: Recent clinical trial results have suggested that programmed cell death ligand 1 (PD-L1) expression measured by immunohistochemistry may predict response to anti–programmed cell death 1 (PD-1) therapy. Results on the association between PD-L1 expression and survival among patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorensen, Steffen Filskov, Zhou, Wei, Dolled-Filhart, Marisa, Georgsen, Jeanette Baehr, Wang, Zhen, Emancipator, Kenneth, Wu, Dianna, Busch-Sørensen, Michael, Meldgaard, Peter, Hager, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800057/
https://www.ncbi.nlm.nih.gov/pubmed/26947883
http://dx.doi.org/10.1016/j.tranon.2016.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800057/
https://www.ncbi.nlm.nih.gov/pubmed/26947883
http://dx.doi.org/10.1016/j.tranon.2016.01.003

Ejemplares similares